Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits

Mammographic screening before age 50 years is less effective than at older ages and the associated radiation risks are higher. We estimated how many breast cancer deaths could be caused and how many could be prevented by a decade of annual two-view mammographic screening starting at ages 20, 30 and 40 years, respectively, in the UK; for all women, and for women with first-degree relatives affected with breast cancer. We extrapolated from a radiation risk model to estimate the number of radiation-induced breast cancer deaths, and used results from randomised trials, which suggest a reduction in breast cancer mortality of 10–20% in women invited to screening before age 50 years, to estimate the number of deaths that could be prevented. The net change in breast cancer deaths was defined as the number of radiation-induced deaths minus the number of prevented deaths. For all women, assuming a reduction in mortality from screening of 20%, a decade of annual screening was estimated to induce more deaths than it prevents if started at age 20 years and at age 30 years (net increase=0.86 and 0.37 breast cancer deaths, respectively, per 1000 women screened). The corresponding estimate for screening starting at age 40 years was a net decrease of 0.46 deaths/1000 women screened and a zero net change assuming a 10% mortality reduction. Results for women with first-degree relatives with breast cancer were generally in the same direction but, because their background incidence rates are higher, the net increases or decreases were greater. In conclusion, our estimates suggest that a decade of annual two-view mammographic screening before age 40 years would result in a net increase in breast cancer deaths, and that starting at age 40 years could result in a material net decrease only if breast cancer mortality is reduced by about 20% or more in women screened. Although these calculations were based on a number of uncertain parameters, in general, the conclusions were not altered when these parameters were varied within a feasible range.

[1]  L. Rutqvist,et al.  Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life , 1999, British Journal of Cancer.

[2]  Erik Holmberg,et al.  Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts , 2002, Radiation research.

[3]  E. Ron,et al.  CANCER RISKS FROM MEDICAL RADIATION , 2003, Health physics.

[4]  J. Law,et al.  Cancers detected and induced, and associated risk and benefit, in a breast screening programme. , 2001, The British journal of radiology.

[5]  K C Young,et al.  Radiation doses received in the UK Breast Screening Programme in 2001 and 2002. , 2005, The British journal of radiology.

[6]  R. Doll,et al.  Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. D. de Koning,et al.  Radiation risk of mammography related to benefit in screening programmes: a favourable balance? , 1998, Journal of medical screening.

[8]  N. Hankin Comment on: Non-ionizing radiation, Part 1: Static and extremely low-frequency electric and magnetic fields, International Agency for Research on Cancer (IARC) Monograph (Vol. 80), 2002. , 2003, Health physics.

[9]  R. Goldbohm,et al.  Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.

[10]  Radiation doses in the UK trial of breast screening in women aged 40-48 years. , 2002, The British journal of radiology.

[11]  Emily White,et al.  Factors contributing to mammography failure in women aged 40-49 years. , 2004, Journal of the National Cancer Institute.

[12]  R E Hendrick,et al.  Radiation risk from screening mammography of women aged 40-49 years. , 1997, Journal of the National Cancer Institute. Monographs.

[13]  D. Dance,et al.  Breast dosimetry. , 1999, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[14]  S. Moss,et al.  Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures , 2005, British Journal of Cancer.